Novabridge BiosciencesNBP
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 28 institutions reported holding Novabridge Biosciences (NBP) in their 13F filings, down 10 from Q2 2024. 3 opened new positions and 13 sold out. The largest holders were HHLR Advisors, LTD. ($8.6M), Caligan Partners LP ($4.3M) and Boothbay Fund Management, LLC ($1.8M). 3 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Novabridge Biosciences
- Filed as
- I MAB (Q3 2024)
- CUSIP
- 44975P103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $17K |
| Exits | 13 | $1.7M |
All 13F filers, Q2 2024 → Q3 2024: 280,310 shares bought and 1,220,614 shares sold, net −940,304 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 28 holders
| HHLR Advisors, LTD. | 0.19% | No change | 6,909,220 | $8.6M |
| Caligan Partners LP | 1.38% | Add +3.7% | 3,499,330 | $4.3M |
| Boothbay Fund Management, LLC | 0.06% | Add +2.9% | 1,419,080 | $1.8M |
| Temasek Holdings (Private) Ltd | 0.00% | No change | 566,650 | $703K |
| Two Sigma Advisers, LP | 0.00% | Reduce -13.4% | 499,300 | $619K |
| Two Sigma Investments, LP | 0.00% | Reduce -14.6% | 408,519 | $507K |
| EDBI Pte Ltd | 0.37% | No change | 222,136 | $275K |
| Aberdeen Group plc | 0.00% | No change | 162,580 | $202K |
| Citadel Advisors | 0.00% | Add +154.2% | 98,389 | $122K |
| Alberta Investment Management Corp | 0.00% | No change | 74,723 | $93K |
| Renaissance Technologies | 0.00% | No change | 63,800 | $79K |
| Dimensional Fund Advisors LP | 0.00% | No change | 58,358 | $72K |
| XTX Topco Ltd | 0.00% | Add +140.8% | 43,039 | $53K |
| Mariner, LLC | 0.00% | No change | 31,535 | $39K |
| Morgan Stanley | 0.00% | Add +120.8% | 30,647 | $38K |
| Barclays PLC | 0.00% | No change | 30,370 | $38K |
| Geode Capital Management, LLC | 0.00% | Reduce -35.8% | 22,037 | $27K |
| Susquehanna International Group, LLP | 0.00% | Reduce -57.0% | 13,351 | $17K |
| Millennium Management | 0.00% | Reduce -71.9% | 11,325 | $14K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -32.2% | 10,685 | $13K |
| Freestone Capital Holdings, LLC | 0.00% | New | 10,000 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 4,015 | $5K |
| BlackRock, Inc. | 0.00% | — | 1,438 | $2K |
| Rhumbline Advisers | 0.00% | No change | 1,367 | $2K |
| Legal & General Group Plc | 0.00% | No change | 1,191 | $1K |
| Bank of America Corp. | 0.00% | No change | 568 | $703 |
| Citigroup Inc. | 0.00% | No change | 50 | $62 |
| Simplex Trading, LLC | 0.00% | New | 417 | $0 |
"% of holder's portfolio" is NBP's weight in each manager's 13F, not the share of Novabridge Biosciences the manager owns.